TypeAllBlog & InsightsCase studiesEvents & ConferencesIVD NewsRegulatory UpdatesWhitepapers
SectorAllDigital Health & AIIVDsLaboratoriesMedical DevicesPrecision Medicine & CDx
FDA’s New CDx Pathway vs EU IVDR: Harmonised Science, Diverging Workload

FDA’s New CDx Pathway vs EU IVDR: Harmonised Science, Diverging Workload
27.11.2025
IVD News | Precision Medicine & CDx
FDA Proposes to Down‑Classify Key Oncology Companion Diagnostics to Class II: What CDx Sponsors Need to Know

FDA Proposes to Down‑Classify Key Oncology Companion Diagnostics to Class II: What CDx Sponsors Need to Know
27.11.2025
IVD News, Regulatory Updates | Precision Medicine & CDx
Team-NB clarifies CDx changes under IVDR Annex IX 5.2

Team-NB clarifies CDx changes under IVDR Annex IX 5.2
11.11.2025
Regulatory Updates | Precision Medicine & CDx
Performance studies in gene therapy trials: from assay cut-offs to clinical impact

Performance studies in gene therapy trials: from assay cut-offs to clinical impact
31.10.2025
Blog & Insights | IVDs, Precision Medicine & CDx
Spanish IVD Regulation 2025 – New Royal Decree Updates for IVD Manufacturers, Sponsors, and Labs

Spanish IVD Regulation 2025 – New Royal Decree Updates for IVD Manufacturers, Sponsors, and Labs
21.10.2025
Blog & Insights, IVD News | Digital Health & AI, IVDs, Laboratories, Precision Medicine & CDx
MDx CRO at MPP 2025: Aligning Companion Diagnostics and Drug Development under IVDR

MDx CRO at MPP 2025: Aligning Companion Diagnostics and Drug Development under IVDR
20.10.2025
Events & Conferences | Precision Medicine & CDx
Request the Precision Medicine Services Pack​
Gain access to MDx’s Precision Medicine Services Pack—detailing our capabilities in clinical research, regulatory strategy, and companion diagnostics. Learn how we support pharma, CDx, and advanced therapy developers across the clinical and regulatory lifecycle.